HCPCS Index Logo

HCPCS Codes Alphabetical Index

— Q —  /  — Q9 —

Q9 — One class b and two class c findings
Code added date: 19950101
Code effective date: 19970101
Q9 in HTML format HTML  |  Q9 in PDF (Portable Document Format) PDF  |  Q9 in plain Text format TXT
Q9001 — Assessment by chaplain services
Code added date: 20201001
Code effective date: 20221001
Q9001 in HTML format HTML  |  Q9001 in PDF (Portable Document Format) PDF  |  Q9001 in plain Text format TXT
Q9002 — Counseling, individual, by chaplain services
Code added date: 20201001
Code effective date: 20221001
Q9002 in HTML format HTML  |  Q9002 in PDF (Portable Document Format) PDF  |  Q9002 in plain Text format TXT
Q9003 — Counseling, group, by chaplain services
Code added date: 20201001
Code effective date: 20221001
Q9003 in HTML format HTML  |  Q9003 in PDF (Portable Document Format) PDF  |  Q9003 in plain Text format TXT
Q9004 — Department of veterans affairs whole health partner services
Code added date: 20211001
Code effective date: 20211001
Q9004 in HTML format HTML  |  Q9004 in PDF (Portable Document Format) PDF  |  Q9004 in plain Text format TXT
Q9950 — Injection, sulfur hexafluoride lipid microspheres, per ml
Code added date: 20160101
Code effective date: 20240101
Q9950 in HTML format HTML  |  Q9950 in PDF (Portable Document Format) PDF  |  Q9950 in plain Text format TXT
Q9951 — Low osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
Code added date: 20050401
Code effective date: 20050401
Q9951 in HTML format HTML  |  Q9951 in PDF (Portable Document Format) PDF  |  Q9951 in plain Text format TXT
Q9953 — Injection, iron-based magnetic resonance contrast agent, per ml
Code added date: 20050401
Code effective date: 20050401
Q9953 in HTML format HTML  |  Q9953 in PDF (Portable Document Format) PDF  |  Q9953 in plain Text format TXT
Q9954 — Oral magnetic resonance contrast agent, per 100 ml
Code added date: 20050401
Code effective date: 20050401
Q9954 in HTML format HTML  |  Q9954 in PDF (Portable Document Format) PDF  |  Q9954 in plain Text format TXT
Q9955 — Injection, perflexane lipid microspheres, per ml
Code added date: 20050401
Code effective date: 20050401
Q9955 in HTML format HTML  |  Q9955 in PDF (Portable Document Format) PDF  |  Q9955 in plain Text format TXT
Q9956 — Injection, octafluoropropane microspheres, per ml
Code added date: 20050401
Code effective date: 20050401
Q9956 in HTML format HTML  |  Q9956 in PDF (Portable Document Format) PDF  |  Q9956 in plain Text format TXT
Q9957 — Injection, perflutren lipid microspheres, per ml
Code added date: 20050401
Code effective date: 20050401
Q9957 in HTML format HTML  |  Q9957 in PDF (Portable Document Format) PDF  |  Q9957 in plain Text format TXT
Q9958 — High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml
Code added date: 20050701
Code effective date: 20050701
Q9958 in HTML format HTML  |  Q9958 in PDF (Portable Document Format) PDF  |  Q9958 in plain Text format TXT
Q9959 — High osmolar contrast material, 150-199 mg/ml iodine concentration, per ml
Code added date: 20050701
Code effective date: 20050701
Q9959 in HTML format HTML  |  Q9959 in PDF (Portable Document Format) PDF  |  Q9959 in plain Text format TXT
Q9960 — High osmolar contrast material, 200-249 mg/ml iodine concentration, per ml
Code added date: 20050701
Code effective date: 20050701
Q9960 in HTML format HTML  |  Q9960 in PDF (Portable Document Format) PDF  |  Q9960 in plain Text format TXT
Q9961 — High osmolar contrast material, 250-299 mg/ml iodine concentration, per ml
Code added date: 20050701
Code effective date: 20050701
Q9961 in HTML format HTML  |  Q9961 in PDF (Portable Document Format) PDF  |  Q9961 in plain Text format TXT
Q9962 — High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml
Code added date: 20050701
Code effective date: 20050701
Q9962 in HTML format HTML  |  Q9962 in PDF (Portable Document Format) PDF  |  Q9962 in plain Text format TXT
Q9963 — High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml
Code added date: 20050701
Code effective date: 20050701
Q9963 in HTML format HTML  |  Q9963 in PDF (Portable Document Format) PDF  |  Q9963 in plain Text format TXT
Q9964 — High osmolar contrast material, 400 or greater mg/ml iodine concentration, per ml
Code added date: 20050701
Code effective date: 20050701
Q9964 in HTML format HTML  |  Q9964 in PDF (Portable Document Format) PDF  |  Q9964 in plain Text format TXT
Q9965 — Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml
Code added date: 20080101
Code effective date: 20080101
Q9965 in HTML format HTML  |  Q9965 in PDF (Portable Document Format) PDF  |  Q9965 in plain Text format TXT
Q9966 — Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml
Code added date: 20080101
Code effective date: 20080101
Q9966 in HTML format HTML  |  Q9966 in PDF (Portable Document Format) PDF  |  Q9966 in plain Text format TXT
Q9967 — Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
Code added date: 20080101
Code effective date: 20080101
Q9967 in HTML format HTML  |  Q9967 in PDF (Portable Document Format) PDF  |  Q9967 in plain Text format TXT
Q9968 — Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg
Code added date: 20100101
Code effective date: 20140101
Q9968 in HTML format HTML  |  Q9968 in PDF (Portable Document Format) PDF  |  Q9968 in plain Text format TXT
Q9969 — Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose
Code added date: 20130101
Code effective date: 20130101
Q9969 in HTML format HTML  |  Q9969 in PDF (Portable Document Format) PDF  |  Q9969 in plain Text format TXT
Q9970 — Injection, ferric carboxymaltose, 1mg
Code added date: 20140701
Code effective date: 20150101
Q9970 in HTML format HTML  |  Q9970 in PDF (Portable Document Format) PDF  |  Q9970 in plain Text format TXT
Q9972 — Injection, epoetin beta, 1 microgram, (for esrd on dialysis)
Code added date: 20140701
Code effective date: 20150101
Q9972 in HTML format HTML  |  Q9972 in PDF (Portable Document Format) PDF  |  Q9972 in plain Text format TXT
Q9973 — Injection, epoetin beta, 1 microgram, (non-esrd use)
Code added date: 20140701
Code effective date: 20150101
Q9973 in HTML format HTML  |  Q9973 in PDF (Portable Document Format) PDF  |  Q9973 in plain Text format TXT
Q9974 — Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg
Code added date: 20140701
Code effective date: 20150101
Q9974 in HTML format HTML  |  Q9974 in PDF (Portable Document Format) PDF  |  Q9974 in plain Text format TXT
Q9975 — Injection, factor viii fc fusion protein (recombinant), per iu
Code added date: 20150401
Code effective date: 20160101
Q9975 in HTML format HTML  |  Q9975 in PDF (Portable Document Format) PDF  |  Q9975 in plain Text format TXT
Q9976 — Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron
Code added date: 20150701
Code effective date: 20160101
Q9976 in HTML format HTML  |  Q9976 in PDF (Portable Document Format) PDF  |  Q9976 in plain Text format TXT
Q9977 — Compounded drug, not otherwise classified
Code added date: 20150701
Code effective date: 20160101
Q9977 in HTML format HTML  |  Q9977 in PDF (Portable Document Format) PDF  |  Q9977 in plain Text format TXT
Q9978 — Netupitant 300 mg and palonosetron 0.5 mg
Code added date: 20150701
Code effective date: 20160101
Q9978 in HTML format HTML  |  Q9978 in PDF (Portable Document Format) PDF  |  Q9978 in plain Text format TXT
Q9979 — Injection, alemtuzumab, 1 mg
Code added date: 20151001
Code effective date: 20160101
Q9979 in HTML format HTML  |  Q9979 in PDF (Portable Document Format) PDF  |  Q9979 in plain Text format TXT
Q9980 — Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg
Code added date: 20160101
Code effective date: 20170101
Q9980 in HTML format HTML  |  Q9980 in PDF (Portable Document Format) PDF  |  Q9980 in plain Text format TXT
Q9981 — Rolapitant, oral, 1 mg
Code added date: 20160701
Code effective date: 20170101
Q9981 in HTML format HTML  |  Q9981 in PDF (Portable Document Format) PDF  |  Q9981 in plain Text format TXT
Q9982 — Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
Code added date: 20160701
Code effective date: 20250101
Q9982 in HTML format HTML  |  Q9982 in PDF (Portable Document Format) PDF  |  Q9982 in plain Text format TXT
Q9983 — Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries
Code added date: 20160701
Code effective date: 20250101
Q9983 in HTML format HTML  |  Q9983 in PDF (Portable Document Format) PDF  |  Q9983 in plain Text format TXT
Q9984 — Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg
Code added date: 20170701
Code effective date: 20180101
Q9984 in HTML format HTML  |  Q9984 in PDF (Portable Document Format) PDF  |  Q9984 in plain Text format TXT
Q9985 — Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
Code added date: 20170701
Code effective date: 20180101
Q9985 in HTML format HTML  |  Q9985 in PDF (Portable Document Format) PDF  |  Q9985 in plain Text format TXT
Q9986 — Injection, hydroxyprogesterone caproate, (makena), 10 mg
Code added date: 20170701
Code effective date: 20180101
Q9986 in HTML format HTML  |  Q9986 in PDF (Portable Document Format) PDF  |  Q9986 in plain Text format TXT
Q9987 — Pathogen(s) test for platelets
Code added date: 20170701
Code effective date: 20180101
Q9987 in HTML format HTML  |  Q9987 in PDF (Portable Document Format) PDF  |  Q9987 in plain Text format TXT
Q9988 — Platelets, pheresis, pathogen-reduced, each unit
Code added date: 20170701
Code effective date: 20180101
Q9988 in HTML format HTML  |  Q9988 in PDF (Portable Document Format) PDF  |  Q9988 in plain Text format TXT
Q9989 — Ustekinumab, for intravenous injection, 1 mg
Code added date: 20170701
Code effective date: 20180101
Q9989 in HTML format HTML  |  Q9989 in PDF (Portable Document Format) PDF  |  Q9989 in plain Text format TXT
Q9991 — Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
Code added date: 20180701
Code effective date: 20180701
Q9991 in HTML format HTML  |  Q9991 in PDF (Portable Document Format) PDF  |  Q9991 in plain Text format TXT
Q9992 — Injection, buprenorphine extended-release (sublocade), greater than 100 mg
Code added date: 20180701
Code effective date: 20180701
Q9992 in HTML format HTML  |  Q9992 in PDF (Portable Document Format) PDF  |  Q9992 in plain Text format TXT
Q9993 — Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
Code added date: 20180701
Code effective date: 20190101
Q9993 in HTML format HTML  |  Q9993 in PDF (Portable Document Format) PDF  |  Q9993 in plain Text format TXT
Q9994 — In-line cartridge containing digestive enzyme(s) for enteral feeding, each
Code added date: 20180701
Code effective date: 20190101
Q9994 in HTML format HTML  |  Q9994 in PDF (Portable Document Format) PDF  |  Q9994 in plain Text format TXT
Q9995 — Injection, emicizumab-kxwh, 0.5 mg
Code added date: 20180701
Code effective date: 20190101
Q9995 in HTML format HTML  |  Q9995 in PDF (Portable Document Format) PDF  |  Q9995 in plain Text format TXT
Q9996 — Injection, ustekinumab-ttwe (pyzchiva), subcutaneous, 1 mg
Code added date: 20250101
Code effective date: 20250101
Q9996 in HTML format HTML  |  Q9996 in PDF (Portable Document Format) PDF  |  Q9996 in plain Text format TXT
Q9997 — Injection, ustekinumab-ttwe (pyzchiva), intravenous, 1 mg
Code added date: 20250101
Code effective date: 20250101
Q9997 in HTML format HTML  |  Q9997 in PDF (Portable Document Format) PDF  |  Q9997 in plain Text format TXT
Q9998 — Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg
Code added date: 20250101
Code effective date: 20250701
Q9998 in HTML format HTML  |  Q9998 in PDF (Portable Document Format) PDF  |  Q9998 in plain Text format TXT
Q9999 — Injection, ustekinumab-aauz (otulfi), biosimilar, 1 mg
Code added date: 20250401
Code effective date: 20250401
Q9999 in HTML format HTML  |  Q9999 in PDF (Portable Document Format) PDF  |  Q9999 in plain Text format TXT